proton pump inhibitor

Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points
G M Hawkey, A T Cole, A S McIntyre, R G Long, C J Hawkey

Gut Sep 2001, 49 (3) 372-379; DOI: 10.1136/gut.49.3.372
Proton pump inhibitor-therapy refractory gastro-oesophageal reflux disease patients, who are they?
Albert J Bredenoord, John Dent

Gut Apr 2007, 56 (4) 593-594; DOI: 10.1136/gut.2006.115287
Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application?
J P Galmiche

Gut Oct 2006, 55 (10) 1379-1381; DOI: 10.1136/gut.2006.098806
Functional dyspepsia: bye-bye to PPIs
O Nyrén

Gut Oct 2002, 51 (4) 464-465; DOI: 10.1136/gut.51.4.464
Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients
W M Wong, B C Y Wong, W K Hung, Y K Yee, A W C Yip, M L Szeto, F M Y Fung, T S M Tong, K C Lai, W H C Hu, M F Yuen, S K Lam

Gut Oct 2002, 51 (4) 502-506; DOI: 10.1136/gut.51.4.502
Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis
Ryota Niikura, Yoku Hayakawa, Yoshihiro Hirata, Atsuo Yamada, Mitsuhiro Fujishiro, Kazuhiko Koike

Gut Oct 2018, 67 (10) 1908-1910; DOI: 10.1136/gutjnl-2017-315710

Main menu